Results
Type
Country of origin
Qualifications

Limaprost | compare suppliers & send inquiries for free

Here you will find a list of producers, manufacturers and traders of Limaprost. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Hungary Chinoin
Type: Producer
Produced in: Hungary
Hungary
South Korea Yonsung Fine Chem.
Type: Producer
Produced in: South Korea
South Korea
Japan Kanto Chemical
Type: Producer
Produced in: Japan
Japan

Looking for Limaprost 74397-12-9?

API | Excipient name:
Limaprost 
Synonyms:
 
Cas Number:
74397-12-9 
DrugBank number:
DB09211 
Unique Ingredient Identifier:
L02U804092

About Limaprost

Learn more about Limaprost. Limaprost (as Limaprost alfadex; CAS number 88852-12-4) is an oral prostaglandin E1 analog. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostaglandins have a wide variety of actions, including, but not limited to muscular constriction and mediation of inflammation.

Limaprost alfadex has been shown to improve peripheral circulatory failure with a vasodilator action and an antithrombotic effect. It also improves poor blood flow in the nerve tissue in cervical spondylosis and normalizes nerve function. Limaprost alfadex was discovered from collaborative research between Ono Pharmaceutical (Ono) and Dainippon Sumitomo Pharma (DSP). It was approved for the treatment of ischemic symptoms such as skin ulcer, pain and coldness accompanying thromboangiitis obliterans in 1988; and for the treatment of subjective symptoms such as pain and numbness in the lower leg and walking disability associated with acquired lumbar spinal canal stenosis as an additional indication in 2001. The drug has been sold under the trade name of Opalmon® Tablets by Ono and Prorenal® Tablets by DSP. In 2011, Ono and DSP initiated Phase II clinical trials in Japan for the treatment of carpal tunnel syndrome. In 2013, these trials were discontinued because the study failed to demonstrate efficacy. Ono and DSP also discontinued the development of limaprost alfadex for the additional indication of cervical spondylosis in 2008 due to the failure to demonstrate the anticipated efficacy in a Phase II study in patients with the disease. However, it was verified by Seoul National University Hospital in November of 2014 that the study on the efficacy of oral limaprost alfadex after surgery for cervical myelopathy was still ongoing.

You can ask the supplier for more technical information about the product.

Limaprost manufacturers | traders | suppliers
We have 3 companies offering Limaprost from 3 different countries.

Get in contact with the supplier of your choice:

  • Chinoin from Hungary
  • Kanto Chemical from Japan
  • Yonsung Fine Chem. from South Korea

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.